Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2026-01-02 @ 4:09 AM
Study NCT ID:
NCT00856492
Status:
COMPLETED
Last Update Posted:
2017-06-27
First Post:
2009-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04
Start Date Type:
None
Primary Completion Date:
2015-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-04
First Submit QC Date:
None
Study First Post Date:
2009-03-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-15
Results First Submit QC Date:
None
Results First Post Date:
2017-06-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-23
Last Update Post Date:
2017-06-27
Last Update Post Date Type:
ACTUAL